Teva Pharmaceutical Industries Limited (TLV: TEVA)
Israel
· Delayed Price · Currency is ILS · Price in ILA
8,080.00
+368.00 (4.77%)
Dec 22, 2024, 3:49 PM IDT
TLV: TEVA Revenue
Teva Pharmaceutical Industries had revenue of $4.33B USD in the quarter ending September 30, 2024, with 12.52% growth. This brings the company's revenue in the last twelve months to $16.77B, up 9.81% year-over-year. In the year 2023, Teva Pharmaceutical Industries had annual revenue of $15.85B with 6.17% growth.
Revenue (ttm)
$16.77B
Revenue Growth
+9.81%
P/S Ratio
n/a
Revenue / Employee
$459.86K
Employees
36,472
Market Cap
91.39B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 15.85B | 921.00M | 6.17% |
Dec 31, 2022 | 14.93B | -953.00M | -6.00% |
Dec 31, 2021 | 15.88B | -781.00M | -4.69% |
Dec 31, 2020 | 16.66B | -228.00M | -1.35% |
Dec 31, 2019 | 16.89B | -1.38B | -7.57% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTeva Pharmaceutical Industries News
- 4 hours ago - Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio? - Benzinga
- 1 day ago - Teva Pharmaceutical Industries Ltd (TEVA) Announces Upcoming Financial Results Release and ... - GuruFocus
- 1 day ago - Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025 - GlobeNewsWire
- 3 days ago - Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases - Benzinga
- 3 days ago - Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases - Benzinga
- 4 days ago - Sanofi and Teva Achieve Milestone in Ulcerative Colitis Treatment Study - GuruFocus
- 4 days ago - TEVA stock soars 26%: What's going on with Teva Pharmaceuticals? - Invezz
- 4 days ago - Nukkleus, Micron, Teva Pharmaceutical, Quantum Computing, Tesla: Why These 5 Stocks Are On Investors' Radars Today - Benzinga